ImExHS Ltd (ASX: IME) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ImExHS Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$21.89 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
54.05 million
Earnings per share
-0.086
Dividend per share
N/A
Year To Date Return
12.50%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ImExHS Ltd (ASX: IME)
Latest News
No posts found.
IME ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ImExHS Ltd
ImExHS Ltd. engages in the development and sale of its Hiruko software platform. It offers modular imaging system that includes a radiology information system, a cardiology information system, an anatomical pathology and laboratory information system, and a picture archiving and communications system. The company was founded by German Arango, Jorge Marin, Andres Vanegas and Alexander Sanz in 2012, and is headquartered in Mascot, Australia.
IME Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 19 Feb 2026 | $0.41 | $-0.04 | -8.89% | 5,769 | $0.41 | $0.41 | $0.41 |
| 12 Feb 2026 | $0.45 | $0.04 | 9.88% | 8,894 | $0.45 | $0.45 | $0.45 |
| 11 Feb 2026 | $0.41 | $-0.04 | -8.89% | 18,000 | $0.41 | $0.41 | $0.41 |
| 09 Feb 2026 | $0.45 | $0.00 | 0.00% | 3,763 | $0.45 | $0.45 | $0.45 |
| 06 Feb 2026 | $0.45 | $-0.02 | -4.26% | 22,806 | $0.45 | $0.45 | $0.45 |
| 05 Feb 2026 | $0.47 | $0.00 | 0.00% | 6,145 | $0.47 | $0.47 | $0.47 |
| 04 Feb 2026 | $0.47 | $0.02 | 4.44% | 5,000 | $0.47 | $0.47 | $0.47 |
| 02 Feb 2026 | $0.45 | $0.00 | 0.00% | 9,769 | $0.45 | $0.45 | $0.45 |
| 30 Jan 2026 | $0.45 | $0.05 | 12.50% | 46,874 | $0.41 | $0.45 | $0.41 |
| 29 Jan 2026 | $0.40 | $0.00 | 0.00% | 7,518 | $0.41 | $0.41 | $0.40 |
| 21 Jan 2026 | $0.40 | $-0.01 | -2.44% | 2,082 | $0.40 | $0.40 | $0.40 |
| 20 Jan 2026 | $0.41 | $0.01 | 2.50% | 18,500 | $0.40 | $0.41 | $0.40 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 30 Dec 2025 | Douglas (Doug) Flynn | Buy | 160,573 | $62,623 |
Off-market trade.
|
| 30 Dec 2025 | Douglas (Doug) Flynn | Sell | 160,573 | $62,623 |
Off-market trade.
|
| 30 Dec 2025 | Damian Banks | Buy | 80,287 | $31,311 |
Off-market trade.
|
| 30 Dec 2025 | Damian Banks | Sell | 80,287 | $31,311 |
Off-market trade.
|
| 23 Dec 2025 | Douglas (Doug) Flynn | Issued | 53,604 | $20,160 |
Director remuneration.
|
| 23 Dec 2025 | German Arango | Expiry | 53,520 | $19,802 |
Options expired.
|
| 23 Dec 2025 | Damian Banks | Issued | 26,802 | $10,080 |
Director remuneration.
|
| 23 Dec 2025 | Carlos Palacio | Issued | 26,802 | $10,080 |
Director remuneration.
|
| 23 Dec 2025 | Douglas Lingard | Issued | 26,802 | $10,080 |
Director remuneration.
|
| 08 Sep 2025 | Douglas Lingard | Issued | 53,485 | $20,115 |
Director remuneration.
|
| 08 Sep 2025 | Carlos Palacio | Issued | 53,485 | $20,115 |
Director remuneration.
|
| 08 Sep 2025 | Damian Banks | Issued | 53,485 | $20,115 |
Director remuneration.
|
| 08 Sep 2025 | Douglas (Doug) Flynn | Issued | 106,969 | $40,230 |
Director remuneration.
|
| 22 May 2025 | Douglas (Doug) Flynn | Issued | 1,328,572 | $465,000 |
Placement.
|
| 22 May 2025 | Douglas (Doug) Flynn | Issued | 74,711 | $25,401 |
Issue of options.
|
| 22 May 2025 | Damian Banks | Issued | 37,356 | $12,701 |
Issue of options.
|
| 22 May 2025 | Damian Banks | Issued | 328,572 | $115,000 |
Placement. As per announcement on 23-05-2025
|
| 22 May 2025 | Douglas Lingard | Issued | 37,356 | $12,701 |
Issue of options.
|
| 22 May 2025 | Douglas Lingard | Issued | 542,858 | $190,000 |
Placement.
|
| 22 May 2025 | German Arango | Issued | 175,810 | $59,775 |
Issue of options.
|
| 22 May 2025 | German Arango | Issued | 328,572 | $115,000 |
Placement.
|
| 22 May 2025 | Carlos Palacio | Issued | 37,356 | $12,701 |
Issue of options.
|
| 22 May 2025 | Carlos Palacio | Issued | 328,572 | $115,000 |
Placement.
|
| 21 May 2025 | Douglas (Doug) Flynn | Transfer | 120,199 | $39,665 |
Off-market transfer.
|
| 21 May 2025 | Douglas (Doug) Flynn | Transfer | 120,199 | $39,665 |
Off-market transfer.
|
| 19 May 2025 | Damian Banks | Transfer | 60,099 | $20,734 |
Off-market transfer.
|
| 19 May 2025 | Damian Banks | Transfer | 60,099 | $20,734 |
Off-market transfer.
|
| 09 May 2025 | Carlos Palacio | Issued | 47,664 | $16,444 |
Exercise of options.
|
| 09 May 2025 | Carlos Palacio | Exercise | 47,664 | $16,444 |
Exercise of options.
|
| 02 Apr 2025 | Carlos Palacio | Issued | 26,683 | $10,035 |
Director remuneration.
|
| 02 Apr 2025 | Douglas Lingard | Issued | 26,683 | $10,035 |
Director remuneration.
|
| 02 Apr 2025 | German Arango | Expiry | 49,173 | $19,423 |
Options expired. As per announcement on 02-04-2025
|
| 02 Apr 2025 | Douglas (Doug) Flynn | Issued | 53,365 | $20,070 |
Director remuneration.
|
| 02 Apr 2025 | Damian Banks | Issued | 26,683 | $10,035 |
Director remuneration.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Douglas (Doug) Ronald Flynn | Non-Executive ChairmanNon-Executive Director | Mar 2020 |
Mr Flynn is an international business leader with a track record of running companies in Europe and Australia. He has experience in various industries, including manufacturing and mining services, business services, media, advertising and marketing services, and human resources. Throughout his career, Mr Flynn has held executive and non-executive roles in several companies, including ICI, Rentokil Initial, NewsCorp, Aegis Group, West Australian Newspapers, Seven West Media, APN Outdoor, NextDC, and Konekt Limited. In the UK, Mr Flynn held leadership positions at News International, Aegis Group, and Rentokil Initial. Currently, he is the chair of NextDC Ltd. He is a member of the Risk Committee.
|
| Mr Damian Eric Banks | Non-Executive Director | May 2020 |
Mr. Banks is a business leader with a track record in the development and expansion of businesses in healthcare, employment, and banking industries. He has a focus on financial management, technology, and people, as well as a strong history of developing customer-focused cultures. Mr. Banks has also completed several M&A transactions. His most recent executive position was as the Managing Director and CEO of Konekt Limited, a technology-focused healthcare and employment company. Prior to this, Mr. Banks held several leadership roles with Westpac Banking Corporation. Currently, Mr. Banks serves as director for Boom Logistics and Chairman of Kip McGrath Education Centres. He is Chair of the Risk Committee.
|
| Dr German Arango | Chief Executive OfficerManaging Director | Aug 2018 |
Dr Arango has over 19 years of experience as a practicing radiologist in Colombia. He also has a residency in Radiology and Diagnostic Imaging from Universidad de La Sabana, and a visiting fellowship in Neuroradiology from the Medical College of Georgia. Dr. Arango has served as a professor of Neuroradiology for radiology, neurology, neurosurgery, and maxillofacial surgery residency programs at several universities in Colombia.
|
| Mr Carlos Jaime Palacio | Non-Executive Director | Aug 2018 |
Mr. Palacio is an entrepreneur with a proven track record in international IT, telecommunications, and strategic management. Mr. Palacio founded and served as the CEO of Crosspoint Telecommunications, a company that provided managed IT services globally, with operations in Australia and SE Asia. He led the sale of the company in 2022. He is a member of the Risk Committee.
|
| Dr Douglas Lingard | Non-Executive Director | Dec 2018 |
Dr Lingard is a qualified radiologist and nuclear physician with international medical and commercial experience, having held leadership positions in Auckland, Washington DC, and Sydney. In Australia, he co-founded Pittwater Radiology Partners which after several acquisitions merged and listed on the ASX as Medical Imaging Australasia Ltd. He is a Senior Fellow of FINSIA and a member of the Australian Institute of Company Directors. He is the founder and present chairman of the Mito Foundation, the peak charity for mitochondrial disease in Australia. He is a member of the Risk Committee.
|
| Ms Reena Minhas | Chief Financial OfficerCompany Secretary | Oct 2020 |
-
|
| Reena Minhas | Chief Financial Officer |
-
|
|
| Reena Minhas | Chief Financial OfficerCompany Secretary |
-
|
|
| Jorge Marin | Chief Medical Officer & Co-founder |
-
|
|
| Orlando Joven | Chief Operations Officer |
-
|
|
| Sandra Nino | Medical Director |
-
|
|
| Elizabeth Mendez | Operations Manager and Contract Audit |
-
|
|
| Juan David Fajardo | VP of Global Sales |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Sandhurst Trustees Ltd (Jmfg Consol A/C) | 8,532,461 | 18.59% |
| Digital Imaging Solutions Sas | 3,407,708 | 7.43% |
| HSBC Custody Nominees (Australia) Limited | 2,102,044 | 4.58% |
| Jaava Asesores Integrales Sas | 2,048,758 | 4.46% |
| DR & LC Flynn Nominees Pty Limited (Flynn Super Fund A/C) | 2,020,845 | 4.40% |
| German Anibal Arango Bonnet | 1,860,394 | 4.05% |
| Dixson Trust Pty Limited | 1,673,329 | 3.65% |
| Rio Negro Pty Ltd (The Medallo A/C) | 1,517,326 | 3.31% |
| Volegna Holdings Pty Ltd (The Csa A/C) | 1,448,524 | 3.16% |
| Mr Christian James Haustead | 1,437,000 | 3.13% |
| Irukandji Investments Pty Ltd (Longreach Family A/C) | 1,170,184 | 2.55% |
| J P Morgan Nominees Australia Pty Limited | 1,122,724 | 2.45% |
| Ilewise Pty Ltd (Lingard Super Fund A/C) | 945,803 | 2.06% |
| Barrijag Pty Limited (Hadley Family A/C) | 909,091 | 1.98% |
| Jorge H Marin Munoz | 884,671 | 1.93% |
| Heff Super Pty Ltd (J & A Heff Super Fund A/C) | 472,221 | 1.03% |
| Ilewise Pty Ltd (Lingard Family A/C) | 465,909 | 1.02% |
| Goldstake Corporation Pty Ltd | 444,938 | 0.97% |
| Dr Vern Thomas Madden & Mrs Clare Maree Madden (Mad Boy Super Fund A/C) | 409,000 | 0.89% |
| Prof Alan Jonathan Berrick | 382,079 | 0.83% |
